Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid

SH2D4A Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN983685

Kurzübersicht für SH2 Domain Containing 4A (SH2D4A) (N-Term) Peptid (ABIN983685)

Target

SH2D4A (SH2 Domain Containing 4A (SH2D4A))

Spezies

Human

Quelle

  • 4
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    N-Term

    Sequenz

    IWKKVAEKEE LEQGSRPAPT LEEEKIRSLS SSSRNIQQML ADSINRMKAY

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-SH2D4A Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    SH2D4A (SH2 Domain Containing 4A (SH2D4A))

    Hintergrund

    SH2D4A inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. SH2D4A may play a role in T-cell development and function.

    Alias Symbols: FLJ20967, SH2A, PPP1R38

    Protein Size: 454

    Molekulargewicht

    53 kDa

    Gen-ID

    63898

    NCBI Accession

    NM_022071, NP_071354

    UniProt

    Q9H788
Sie sind hier:
Chat with us!